In vivo quantification of mouse autoimmune arthritis by PET/CT

Smriti Kundu-Raychaudhuri, Anupam Mitra, Ananya Datta-Mitra, Abhijit Chaudhari, Siba P Raychaudhuri

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Aim: To quantify the progression and severity of mouse collagen-induced arthritis (CIA) using an in vivo imaging tool, 18F-fluorodeoxyglucose (18F-FDG) PET/CT and validate it against gold standard 'histopathological' evaluation. Method: The PET radiotracer 18F-FDG, a marker for glucose metabolism, was injected in mice at different stages of CIA and the radiotracer distribution was imaged using a PET scanner. A sequential CT scan provided correlated anatomy. Radiotracer concentration was derived from PET/CT images for individual limb joints and on a per-limb basis at different stages of the disease. The imaging outcomes were subjected to correlation analysis with concurrently measured clinical and histological score. Results: Clinical and histological score, and hence disease severity, showed a strong linear correlation (r2 = 0.71, P = 0.001 and r2 = 0.87, P < 0.001, respectively) with radiotracer concentration measured from PET/CT during the progression of CIA. Conclusions: The strong positive correlation of the 18F-FDG PET/CT findings with the histopathological evaluation at different stages of the disease suggest the potential of this imaging tool for the non-invasive assessment of progression and severity in mouse autoimmune arthritis. Thus, in preclinical studies, 18F-FDG PET/CT can be considered as a non-invasive tool to develop novel therapies of inflammatory arthritis.

Original languageEnglish (US)
JournalInternational Journal of Rheumatic Diseases
DOIs
StateAccepted/In press - 2014

Fingerprint

Fluorodeoxyglucose F18
Arthritis
Experimental Arthritis
Extremities
Anatomy
Joints
Glucose
Therapeutics

Keywords

  • in vivo imaging
  • Inflammation
  • Mouse CIA
  • PET/CT
  • Quantification

ASJC Scopus subject areas

  • Rheumatology

Cite this

In vivo quantification of mouse autoimmune arthritis by PET/CT. / Kundu-Raychaudhuri, Smriti; Mitra, Anupam; Datta-Mitra, Ananya; Chaudhari, Abhijit; Raychaudhuri, Siba P.

In: International Journal of Rheumatic Diseases, 2014.

Research output: Contribution to journalArticle

@article{ee5725bbc2a040ed9836095b6e224a7b,
title = "In vivo quantification of mouse autoimmune arthritis by PET/CT",
abstract = "Aim: To quantify the progression and severity of mouse collagen-induced arthritis (CIA) using an in vivo imaging tool, 18F-fluorodeoxyglucose (18F-FDG) PET/CT and validate it against gold standard 'histopathological' evaluation. Method: The PET radiotracer 18F-FDG, a marker for glucose metabolism, was injected in mice at different stages of CIA and the radiotracer distribution was imaged using a PET scanner. A sequential CT scan provided correlated anatomy. Radiotracer concentration was derived from PET/CT images for individual limb joints and on a per-limb basis at different stages of the disease. The imaging outcomes were subjected to correlation analysis with concurrently measured clinical and histological score. Results: Clinical and histological score, and hence disease severity, showed a strong linear correlation (r2 = 0.71, P = 0.001 and r2 = 0.87, P < 0.001, respectively) with radiotracer concentration measured from PET/CT during the progression of CIA. Conclusions: The strong positive correlation of the 18F-FDG PET/CT findings with the histopathological evaluation at different stages of the disease suggest the potential of this imaging tool for the non-invasive assessment of progression and severity in mouse autoimmune arthritis. Thus, in preclinical studies, 18F-FDG PET/CT can be considered as a non-invasive tool to develop novel therapies of inflammatory arthritis.",
keywords = "in vivo imaging, Inflammation, Mouse CIA, PET/CT, Quantification",
author = "Smriti Kundu-Raychaudhuri and Anupam Mitra and Ananya Datta-Mitra and Abhijit Chaudhari and Raychaudhuri, {Siba P}",
year = "2014",
doi = "10.1111/1756-185X.12410",
language = "English (US)",
journal = "International Journal of Rheumatic Diseases",
issn = "1756-1841",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - In vivo quantification of mouse autoimmune arthritis by PET/CT

AU - Kundu-Raychaudhuri, Smriti

AU - Mitra, Anupam

AU - Datta-Mitra, Ananya

AU - Chaudhari, Abhijit

AU - Raychaudhuri, Siba P

PY - 2014

Y1 - 2014

N2 - Aim: To quantify the progression and severity of mouse collagen-induced arthritis (CIA) using an in vivo imaging tool, 18F-fluorodeoxyglucose (18F-FDG) PET/CT and validate it against gold standard 'histopathological' evaluation. Method: The PET radiotracer 18F-FDG, a marker for glucose metabolism, was injected in mice at different stages of CIA and the radiotracer distribution was imaged using a PET scanner. A sequential CT scan provided correlated anatomy. Radiotracer concentration was derived from PET/CT images for individual limb joints and on a per-limb basis at different stages of the disease. The imaging outcomes were subjected to correlation analysis with concurrently measured clinical and histological score. Results: Clinical and histological score, and hence disease severity, showed a strong linear correlation (r2 = 0.71, P = 0.001 and r2 = 0.87, P < 0.001, respectively) with radiotracer concentration measured from PET/CT during the progression of CIA. Conclusions: The strong positive correlation of the 18F-FDG PET/CT findings with the histopathological evaluation at different stages of the disease suggest the potential of this imaging tool for the non-invasive assessment of progression and severity in mouse autoimmune arthritis. Thus, in preclinical studies, 18F-FDG PET/CT can be considered as a non-invasive tool to develop novel therapies of inflammatory arthritis.

AB - Aim: To quantify the progression and severity of mouse collagen-induced arthritis (CIA) using an in vivo imaging tool, 18F-fluorodeoxyglucose (18F-FDG) PET/CT and validate it against gold standard 'histopathological' evaluation. Method: The PET radiotracer 18F-FDG, a marker for glucose metabolism, was injected in mice at different stages of CIA and the radiotracer distribution was imaged using a PET scanner. A sequential CT scan provided correlated anatomy. Radiotracer concentration was derived from PET/CT images for individual limb joints and on a per-limb basis at different stages of the disease. The imaging outcomes were subjected to correlation analysis with concurrently measured clinical and histological score. Results: Clinical and histological score, and hence disease severity, showed a strong linear correlation (r2 = 0.71, P = 0.001 and r2 = 0.87, P < 0.001, respectively) with radiotracer concentration measured from PET/CT during the progression of CIA. Conclusions: The strong positive correlation of the 18F-FDG PET/CT findings with the histopathological evaluation at different stages of the disease suggest the potential of this imaging tool for the non-invasive assessment of progression and severity in mouse autoimmune arthritis. Thus, in preclinical studies, 18F-FDG PET/CT can be considered as a non-invasive tool to develop novel therapies of inflammatory arthritis.

KW - in vivo imaging

KW - Inflammation

KW - Mouse CIA

KW - PET/CT

KW - Quantification

UR - http://www.scopus.com/inward/record.url?scp=84902931047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902931047&partnerID=8YFLogxK

U2 - 10.1111/1756-185X.12410

DO - 10.1111/1756-185X.12410

M3 - Article

C2 - 24965561

AN - SCOPUS:84902931047

JO - International Journal of Rheumatic Diseases

JF - International Journal of Rheumatic Diseases

SN - 1756-1841

ER -